健尔康 (603205)

Jianerkang Medical Co., Ltd.

ASH

Tags

SSE 580 IndexSpecial Purpose Equipment ManufacturingTwo-Year Newly Listed StocksMedical DevicesPharmaceuticals and HealthcareImminent Lock-up ExpirationInfant and Child ConceptOverseas BusinessMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 15600.00
  • Circulating A-Shares(W): 4134.00
  • Earnings Per Share(RMB): 0.4900
  • Net Assets Per Share(RMB): 9.3481
  • Operating Revenue(W RMB): 72538.01
  • Total Profit(W RMB): 8657.05
  • **Net Profit Attributable to Parent(W RMB) **: 7640.96
  • Net Profit Growth Rate(%): -18.24
  • Weighted Return on Equity(%): 5.3000
  • Operating Cash Flow Per Share(RMB): 0.7070
  • Undistributed Profit Per Share(RMB): 3.6431
  • Capital Reserve Per Share(RMB): 4.3522

2. Main Business

The main business covers:

  • Research, development, production, and sales of medical dressings and other disposable medical devices.
  • Research, development, production, and sales of disinfection and hygiene products.

3. Company Basic Information

  • Company Name: Jianerkang Medical Technology Co., Ltd.
  • Listing Date: 2024-11-07
  • Industry: Special Purpose Equipment Manufacturing
  • Address: No. 1 Jianerkang Road, Industrial Concentration Area, Zhixi Town, Jintan District, Changzhou City, Jiangsu Province
  • Website: https://www.chinajek.com
  • Company Profile: The issuer is a joint stock company established through the overall change of Jianerkang Co., Ltd. On October 21, 2020, Deloitte Touche Tohmatsu Certified Public Accountants issued an audit report. As of July 31, 2020, the company's audited net assets were RMB 456,432,344.10. On October 25, 2020, Shanghai Lixin Asset Appraisal Co., Ltd. issued an asset appraisal report. Based on the appraisal as of July 31, 2020, the assessed net asset value of Jianerkang Co., Ltd. was RMB 695.2231 million. On October 26, 2020, Jianerkang Co., Ltd. passed a resolution at the shareholders' meeting, agreeing to change wholly to a joint stock company. Using the audited net assets of RMB 456,432,344.10 as of July 31, 2020, and according to a 1:0.1972 ratio, it was converted into 90 million shares of the joint stock company, with a par value of RMB 1.00 per share, and the remainder was entered into the capital reserve.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Yongying CSI All Share Medical Device Trading Open-end Index Securities Investment Fund Fund 28.51 0.73

5. Concept Sectors

  • Secondary New Stock
  • Baby & Child Concept
  • Margin Trading & Securities Lending
  • Imminent Lifting of Trading Restrictions
  • Oversold Secondary New Stock
  • Overseas Business
  • SSE 580

Remarks

  • Data update date: 2025-11-07
  • Data source: Public Market Information